Image for illustrative purposes only. Not a real photo.

Chimeric Therapeutics raises $8.4M to fund CHM CDH17 CAR-T trial

Written by Heidi Cuthbert Published Dec 23, 2025, 6:10 AMLast Updated Jul 6, 2026, 10:58 AM

Chimeric Therapeutics (ASX:CHM) has secured $8.4 million to fully fund its lead CHM CDH17 CAR-T Phase 1/2 clinical trial through the end of Phase 1.

More ways to discover